184 related articles for article (PubMed ID: 20153080)
1. Continuing diarrhoea after ten days of oral metronidazole or oral vancomycin for presumed, hospital-acquired Clostridium difficile colitis in elderly hospital patients.
Parks T; Wallis S; Wilson J; Gkrania-Klotsas E; Nicholl C
J Hosp Infect; 2010 Apr; 74(4):403-5. PubMed ID: 20153080
[No Abstract] [Full Text] [Related]
2. Emergence of a highly resistant Clostridium difficile strain (NAP/BI/027) in a tertiary care center in Saudi Arabia.
Alzahrani N; Johani SA
Ann Saudi Med; 2013; 33(2):198-9. PubMed ID: 23563012
[No Abstract] [Full Text] [Related]
3. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
Biswas JS; Patel A; Otter JA; Wade P; Newsholme W; van Kleef E; Goldenberg SD
J Hosp Infect; 2015 Jul; 90(3):267-70. PubMed ID: 25728208
[TBL] [Abstract][Full Text] [Related]
4. Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole.
Abujamel T; Cadnum JL; Jury LA; Sunkesula VC; Kundrapu S; Jump RL; Stintzi AC; Donskey CJ
PLoS One; 2013; 8(10):e76269. PubMed ID: 24098459
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations, treatment and control of infections caused by Clostridium difficile.
Bouza E; Muñoz P; Alonso R
Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():57-64. PubMed ID: 15997485
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Bishara J; Wattad M; Paul M
Clin Infect Dis; 2007 Dec; 45(12):1646-7; author reply 1649-51. PubMed ID: 18190329
[No Abstract] [Full Text] [Related]
7. Toxigenic
Khodaparast S; Mohabati Mobarez A; Khoramabadi N; Vasei M; Saberifiroozi M
Epidemiol Infect; 2021 Aug; 149():e250. PubMed ID: 34372951
[TBL] [Abstract][Full Text] [Related]
8. Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin.
Wilcox MH; Howe R
J Antimicrob Chemother; 1995 Oct; 36(4):673-9. PubMed ID: 8591942
[TBL] [Abstract][Full Text] [Related]
9. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Tart SB
J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.
Tieu JD; Schmidt SA; Miller JL; Kupiec KE; Skrepnek GH; Liu C; Smith WJ
J Oncol Pharm Pract; 2019 Apr; 25(3):520-528. PubMed ID: 29157145
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
Huggan PJ; Murdoch DR
Clin Infect Dis; 2007 Dec; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330
[No Abstract] [Full Text] [Related]
12. Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection.
Popovic N; Korac M; Nesic Z; Milosevic B; Urosevic A; Jevtovic D; Pelemis M; Delic D; Prostran M; Milosevic I
J Infect Dev Ctries; 2015 Oct; 9(10):1062-7. PubMed ID: 26517480
[TBL] [Abstract][Full Text] [Related]
13. Treatment of recurrent Clostridium difficile infection: a systematic review.
O'Horo JC; Jindai K; Kunzer B; Safdar N
Infection; 2014 Feb; 42(1):43-59. PubMed ID: 23839210
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
Pépin J; Valiquette L; Alary ME; Villemure P; Pelletier A; Forget K; Pépin K; Chouinard D
CMAJ; 2004 Aug; 171(5):466-72. PubMed ID: 15337727
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile-associated disease treatment response depends on definition of cure.
Lawrence SJ; Dubberke ER; Johnson S; Gerding DN
Clin Infect Dis; 2007 Dec; 45(12):1648; author reply 1649-51. PubMed ID: 18190331
[No Abstract] [Full Text] [Related]
16. A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity.
Di X; Bai N; Zhang X; Liu B; Ni W; Wang J; Wang K; Liang B; Liu Y; Wang R
Braz J Infect Dis; 2015; 19(4):339-49. PubMed ID: 26001980
[TBL] [Abstract][Full Text] [Related]
17. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
Kimura T; Snijder R; Sugitani T
J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
[TBL] [Abstract][Full Text] [Related]
18. Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study.
Nguyen CT; Li J; Anders S; Garcia-Diaz J; Staffeld-Coit C; Hand J
Transpl Infect Dis; 2018 Jun; 20(3):e12867. PubMed ID: 29512244
[TBL] [Abstract][Full Text] [Related]
19. Preventing downstream Clostridium difficile infections with upstream antibiotic management.
Malkan AD; Scholand SJ
Med Hypotheses; 2012 Jan; 78(1):136-7. PubMed ID: 22079651
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca].
Siller-Ruiz M; Calvo-García N; Hernández-Egido S; María-Blázquez A; de Frutos-Serna M; García-Sánchez JE
Rev Esp Quimioter; 2014 Jun; 27(2):122-6. PubMed ID: 24940894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
